Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma
Sylvie Négrier(Université Claude Bernard Lyon 1), Thomas Tursz(Institut Gustave Roussy)
Cited by 969
Related Papers
Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
|JNCI Journal of the National Cancer Institute|2006|480
Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie
|Annals of Oncology|2002|343
Sunscreen Use and Duration of Sun Exposure: a Double-Blind, Randomized Trial
|JNCI Journal of the National Cancer Institute|1999|239
Prognostic Factors in Primary Breast Sarcomas: A Series of Patients With Long-Term Follow-Up
|Journal of Clinical Oncology|2003|219